90750 Hzv vacc recombinant intramuscular
Medicine
Also known as: Shingrix, Recombinant zoster vaccine, Herpes zoster recombinant
Herpes zoster vaccine, recombinant zoster vaccine (Shingrix), administered intramuscularly for prevention of herpes zoster (shingles) and postherpetic neuralgia.
Clinical Context
Administered to adults 50 years and older in 2-dose series for prevention of herpes zoster recurrence and postherpetic neuralgia; more effective than live vaccine.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.